Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EBOS GROUP EBOS GROUP
Updated on 17 Sep 2021 (End of trading day)
Last (AUD): 35.140 Change: -0.720 High: 35.220 Remarks: -
Change (%): -2.01 Low: 34.300
Open 34.940 Yesterday's Close 35.86
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 5,682 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 1.12866 Trailing EPS (AUD) e 1.12866 NAV (AUD) b 8.5946
PE a 31.134 Trailing PE f 31.134 Price / NAV b 4.0886
Dividend (AUD) d 0.859939 Cash In Hand (AUD) g 1.0291 Issued & Paid-up Shares c 164,175,000
Dividend Yield (%) d 2.447 Price / Cash In Hand g 34.146 Treasury Shares h -
Beta - 75 Daysi -0.042 R-Squared - 75 Days(%)i 0.03 Market Cap (M) 5,769.109
Beta - 500 Daysi 0.203 R-Squared - 500 Days (%)i 0.67 Enterprise Value (M) 6,275.159
Piotroski F Score 5 Exchange Code EBO Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 25.36 Free Float (%) 81.4
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 26 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Aug 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EBOS GROUP ASX 5,769.109 31.134 31.134 4.0886 2.447
Industry Medical Specialties ASX 2,382.337 70.204 70.302 10.4280 0.781
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 18,167.917 37.116 37.116 12.9913 1.324
Local Peer COCHLEAR LTD ASX 15,672.629 48.002 48.002 9.2100 1.070
Local Peer NANOSONICS LIMITED ASX 1,891.164 220.464 220.467 13.9488 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 603.132 - - -422.4490 -
Local Peer INCANNEX HEALTHCARE LTD ASX 443.176 - - 51.9481 -
Local Peer AROA BIOSURGERY LTD ASX 365.793 - - 6.8023 -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 348.341 - - 17.1717 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 296.558 - - 4.3419 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 314.191 - - 4.6940 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 213.588 - - 21.2473 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 199.009 - - 6.6163 -
Local Peer SOMNOMED LIMITED ASX 177.932 - - 5.2917 -
Other Local Peers CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OPTISCAN IMAGING (ASX), MICRO-X LTD (ASX), SDI LTD (ASX), CLEANSPACE HOLDINGS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), DIMERIX LTD (ASX), CARDIEX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), RESONANCE HEALTH LTD (ASX), LBT INNOVATIONS LTD (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ANALYTICA (ASX)
Global Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Global Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Global Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Global Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), ANGELALIGN (HKEx), SOTERA HEALTH CO (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), Top Glove (SGX), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), AK MEDICAL (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NANO-X IMAGING LTD (NASDAQ), INOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), MODERN DENTAL (HKEx), CIRC (HKEx), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SISRAM MED (HKEx), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), INTERCURE LTD (NASDAQ), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOLITON INC (NASDAQ), BASECARE-B (HKEx), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), CONFORMIS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), PW MEDTECH (HKEx), DARIOHEALTH CORP (NASDAQ), INVACARE CORP (NYSE), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INTRICOM CORP (NASDAQ), UGHealthcare (SGX), TELA BIO INC (NASDAQ), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), LENSAR INC (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), ZOSANO PHARMA CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), RGTBHD (Bursa), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SENSUS HEALTHCARE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), YUNNAN ENERGY (HKEx), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), ADVENTA (Bursa), NANOVIBRONIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), LKL (Bursa), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Biolidics (SGX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), CYANOTECH CORP (NASDAQ), LIFE HEALTHCARE (HKEx), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.350
+7.17 %
10 Days -+1.080
+3.17 %
20 Days -+4.000
+12.85 %
Medium Term Return 3 Months -+4.990
+16.55 %
6 Months -+8.140
+30.15 %
1 Year 0.413+12.640
+58.01 %
Long Term Return 2 Years 0.413+12.540
+57.31 %
3 Years 0.413+14.600
+73.09 %
5 Years 0.413+17.090
+96.97 %
Annualised Return Annualised --
+14.52 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 21.400 - 35.860 Change From 1 Year Low +13.740 % Change From 1 Year Low (%) +64.21
Change From 1 Year High -0.720 % Change From 1 Year High (%) -2.01
2 Years Range 18.800 - 35.860 Change From 2 Years Low +16.340 % Change From 2 Years Low (%) +86.91
Change From 2 Years High -0.720 % Change From 2 Years High (%) -2.01
5 Years Range 15.420 - 35.860 Change From 5 Years Low +19.720 % Change From 5 Years Low (%) +127.89
Change From 5 Years High -0.720 % Change From 5 Years High (%) -2.01
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. It operates through the following segments: Healthcare, Animal Care, and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities. The Animal Care segment sells animal care products in a range of sectors, own brands, retail and wholesale activities. The Corporate segment includes net funding costs and central administration expenses. The company was founded on September 11, 1922 and is headquartered in Christchurch, New Zealand.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 34.940 35.220 34.300 35.140 5,682 -
16 Sep 2021 34.210 35.860 34.170 35.860 4,748 -
15 Sep 2021 33.800 34.200 33.650 34.200 1,879 -
14 Sep 2021 34.000 34.000 32.790 33.600 11,308 -
13 Sep 2021 33.100 34.620 32.860 34.000 7,416 -
10 Sep 2021 33.500 33.500 32.110 32.790 9,873 -
09 Sep 2021 33.220 33.460 31.810 32.640 8,004 -
08 Sep 2021 33.700 33.820 33.410 33.680 3,755 -
07 Sep 2021 33.190 33.950 33.190 33.620 10,253 -
06 Sep 2021 33.800 33.910 32.900 33.190 3,777 -
03 Sep 2021 33.950 34.600 33.670 34.060 5,216 -
02 Sep 2021 34.800 34.800 33.630 33.630 5,090 -
01 Sep 2021 34.750 34.750 34.480 34.500 7,072 -
31 Aug 2021 34.000 34.750 34.000 34.620 3,543 -
30 Aug 2021 33.850 34.840 33.810 34.000 4,604 -
27 Aug 2021 33.800 33.860 33.510 33.750 3,888 -
26 Aug 2021 33.500 33.800 33.290 33.800 15,308 -
25 Aug 2021 32.880 33.500 32.880 33.500 8,386 -
24 Aug 2021 32.330 32.860 32.330 32.830 7,640 -
23 Aug 2021 31.970 32.400 31.970 32.400 14,908 -
20 Aug 2021 31.200 31.660 31.120 31.140 7,903 -
19 Aug 2021 30.870 31.940 30.870 30.950 12,135 -
Summary
Current 2 Weeks
(06 Sep 2021 to 17 Sep 2021)
33.800 35.860 31.810 35.140 66,695 -
Previous 2 Weeks
(23 Aug 2021 to 03 Sep 2021)
31.970 35.860 31.810 34.060 75,655 -
4 Weeks from
(26 Jul 2021 to 20 Aug 2021)
29.930 35.860 29.600 31.140 273,688 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.